Published in Thorax on February 01, 2005
Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res (2006) 1.69
Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax (2007) 1.61
Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir Res (2010) 1.27
Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res (2006) 1.22
Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential. PLoS One (2008) 1.19
VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J (2008) 1.18
Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.15
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res (2010) 1.10
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.06
Alveolar macrophage dynamics in murine lung regeneration. J Cell Physiol (2012) 0.99
Increased expression of placenta growth factor in COPD. Thorax (2008) 0.98
Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells. Cell Mol Life Sci (2012) 0.95
Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers. PLoS One (2012) 0.93
Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol (2006) 0.90
Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br J Pharmacol (2011) 0.89
Angiogenesis and vascular endothelial growth factor in COPD. Thorax (2005) 0.89
Future therapeutic treatment of COPD: struggle between oxidants and cytokines. Int J Chron Obstruct Pulmon Dis (2007) 0.89
Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respir Res (2007) 0.87
Angiogenesis in chronic obstructive pulmonary disease: a translational appraisal. Transl Med UniSa (2012) 0.83
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm Med (2009) 0.81
An investigation of the resolution of inflammation (catabasis) in COPD. Respir Res (2012) 0.81
Variants in multiple genes polymorphism association analysis of COPD in the Chinese Li population. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Epac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke. FASEB J (2014) 0.78
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema. Front Physiol (2015) 0.78
Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb. Trends Cardiovasc Med (2010) 0.78
Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease. Med J Islam Repub Iran (2014) 0.78
Cigarette smoke reversibly activates hypoxia-inducible factor 1 in a reactive oxygen species-dependent manner. Sci Rep (2016) 0.78
Why are kids with lupus at an increased risk of cardiovascular disease? Pediatr Nephrol (2015) 0.78
Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD. Int J Endocrinol (2012) 0.77
Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease. Mediators Inflamm (2016) 0.75
Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease. J Thorac Dis (2016) 0.75
From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling. Front Pediatr (2016) 0.75
Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course. Lung (2016) 0.75
Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS One (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Mechanisms of angiogenesis and arteriogenesis. Nat Med (2000) 13.88
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest (2000) 5.26
Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med (2002) 5.10
The molecular basis of lung morphogenesis. Mech Dev (2000) 4.87
Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med (2001) 3.92
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83
Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med (2001) 3.59
FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci (2001) 3.42
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J (2001) 3.20
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem (1994) 2.87
Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol (2003) 2.59
Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.58
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest (1995) 2.30
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol (2001) 2.24
Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis (1980) 2.23
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J (2002) 2.19
Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med (2003) 2.14
Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.59
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol (2000) 1.54
Structural and inflammatory changes in COPD: a comparison with asthma. Thorax (1998) 1.54
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46
The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am Rev Respir Dis (1983) 1.40
Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax (1988) 1.36
Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.29
Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int (2000) 1.26
Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol (1997) 1.25
Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol (1998) 1.24
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy (2003) 1.24
Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat Rec (1999) 1.17
VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung. Dev Dyn (2000) 1.15
Alterations in the immunohistochemical distribution patterns of vascular endothelial growth factor receptors Flk1 and Flt1 in bleomycin-induced rat lung fibrosis. Virchows Arch (1999) 1.05
Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Crit Care Med (2002) 1.03
Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2002) 1.03
Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med (2002) 0.94
Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax (1999) 0.94
Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. Novartis Found Symp (2001) 0.92
Calcium-induced modification of protein conformation demonstrated by immunohistochemistry: What is the signal? J Histochem Cytochem (1999) 0.91
Basic fibroblast growth factor expression precedes flow-induced arterial enlargement. J Surg Res (1998) 0.89
Analysis of intrapulmonary vessels and epithelial-endothelial interactions in the human developing lung. Lab Invest (2002) 0.86
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J (2005) 3.05
[Hyperventilation: not a cause of panic attacks]. Ned Tijdschr Geneeskd (1993) 2.64
Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med (1992) 2.52
Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol (1997) 2.28
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J (1996) 2.05
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J (2004) 1.95
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Sputum induction. Eur Respir J Suppl (2002) 1.88
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax (2001) 1.76
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer (2006) 1.61
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.59
Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med (1997) 1.55
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy (1999) 1.52
Physical properties of aerosols produced by several jet- and ultrasonic nebulizers. Bull Eur Physiopathol Respir (1984) 1.52
Murine models of asthma. Eur Respir J (2003) 1.49
Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med (2001) 1.46
Lung sounds during allergen-induced asthmatic responses in patients with asthma. Am J Respir Crit Care Med (1996) 1.42
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41
Occurrence of a late response to exercise in asthmatic children: multiple regression approach using time-matched baseline and histamine control days. Eur Respir J (1996) 1.40
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy (2008) 1.31
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol (1995) 1.26
Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol (1997) 1.25
Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med (1999) 1.25
Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax (1992) 1.23
Safety of sputum induction. Eur Respir J Suppl (2002) 1.23
Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol (1999) 1.21
Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax (1996) 1.21
Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax (1999) 1.20
Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol (2008) 1.20
Inhaled hyaluronic acid against exercise-induced bronchoconstriction in asthma. Pulm Pharmacol Ther (2005) 1.19
Heat-related deaths are largely due to brain damage. Indian J Med Res (2005) 1.19
Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med (1995) 1.17
Permeability of the blood-brain barrier depends on brain temperature. Neuroscience (2009) 1.17
Three phenotypes of adult-onset asthma. Allergy (2013) 1.15
Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res (1992) 1.13
Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med (1998) 1.11
Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl (2002) 1.10
Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects. Am Rev Respir Dis (1985) 1.08
Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol (2000) 1.08
Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am J Respir Crit Care Med (1996) 1.07
Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy (2001) 1.05
Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy (1997) 1.05
Long-term effects of chemotherapy in patients with testicular cancer. J Clin Oncol (1992) 1.05
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J (2011) 1.03
Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med (1998) 1.03
Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med (2000) 1.03
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol (2000) 1.02
Asthma severity and susceptibility to air pollution. Eur Respir J (1998) 1.02
External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy (2011) 1.02
Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Brain Res Mol Brain Res (1995) 1.02
Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J (1998) 1.02
Tobacco use in relation to COPD and asthma. Eur Respir J (2007) 1.02
Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol (2001) 1.02
Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J (1999) 1.01
Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy (2012) 1.01
Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol (2000) 1.00
Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. Eur Respir J (1998) 1.00
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol (1998) 1.00
Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol (1990) 1.00
Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl (1993) 1.00
CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects. Clin Exp Allergy (1998) 0.99
The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med (1997) 0.98
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J (2006) 0.98
Effects of a high-protein diet in acid maltase deficiency. J Neurol Sci (1989) 0.98
Cloning and sequence analysis of a cDNA encoding poly-ubiquitin in human ovarian granulosa cells. Biochem Biophys Res Commun (1987) 0.97
Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol (2001) 0.97
Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment. Allergy (2008) 0.97
Influence of long-term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. J Neurol Sci (1986) 0.96
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J (2007) 0.96
Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med (1999) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects. Clin Exp Allergy (2003) 0.95
Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med (1999) 0.95
The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis (1990) 0.95
Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group. Am J Respir Crit Care Med (1995) 0.94
Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. J Mol Cell Cardiol (1993) 0.94
Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax (1999) 0.94
Ozone-induced inflammation assessed in sputum and bronchial lavage fluid from asthmatics: a new noninvasive tool in epidemiologic studies on air pollution and asthma. Free Radic Biol Med (1999) 0.93
Cytokine release and its modulation by dexamethasone in whole blood following exercise. Clin Exp Immunol (1998) 0.93
Impairment of blood-brain barrier function by serotonin induces desynchronization of spontaneous cerebral cortical activity: experimental observations in the anaesthetized rat. Neuroscience (1995) 0.93
Airway remodelling: the future. Eur Respir J (2007) 0.92
Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic Biol Med (2000) 0.92
The excretion of leukotriene E4 into urine following inhalation of leukotriene D4 by human individuals. Biochem Biophys Res Commun (1987) 0.92
The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis (1992) 0.92
Small airways function and molecular markers in exhaled air in mild asthma. Thorax (2005) 0.92
Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis. J Pathol (1998) 0.92
Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group. Eur Respir J (1992) 0.91
Impaired structural remodelling of pulmonary arteries in newborns with congenital diaphragmatic hernia: a histological study of 29 cases. J Pathol (1999) 0.91
Association of anxiety with perception of histamine induced bronchoconstriction in patients with asthma. Thorax (1997) 0.90